PD-1 and PD-L 1 inhibitors – Competitive Landscape, Pipeline and Market Analysis, 2016
emerging-pml-treatment
New Approved PML Treatment Options &#...

Progressive multifocal leukoencephalopathy is a severe, progressive, and lethal demyelinating disease that ...

Pharma News for Sarepta and Ionis
Bristol-Myers Squibb’s Opdivo & ...

Bristol-Myers Squibb’s Opdivo and Yervoy Combo Fails in Phase III Trial Bristol-Myers Squibb has reported t...

generalized-myasthenia-gravis-treatment-market
Can FcRn Antagonists Be The Game-Chan...

Though a rare disease, generalized myasthenia gravis (gMG) still affects around 60,000 people in the US and...

adpkd-treatment-outlook
Advancing Therapeutic Outlook for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Treatment

Key Highlights The US approval of Jynarque added the much-needed push to the ADPKD treatment market.In the coming years, Bardoxolone methyl is expected to be an effective therapy for ADPKD trea...


Wilson's Disease Image
Wilson’s Disease Presents Unique Challenges and Demand for Novel Treatment Therapies

Wilson’s disease is a rare genetic disorder caused by mutations in the P-type ATPase gene. Wilson’s disease causes defective biliary excretion of copper, leading to its accumulation, particularly ...


pulmonary arterial hypertension
New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Domain

Pulmonary arterial hypertension is a progressive disease of the lung vascular system, primarily affecting the small pulmonary arterioles. Pulmonary arterial hypertension is defined as mean pulmona...


Pharma News for CG Oncology, Amgen, Elevar, and GSK
CG Oncology Teams Up With Merck & BMS; Parse Biosciences Partners With Molecular Diagnostics...

FDA Gives Green Signal to First Measles Vaccine in Almost 50 Years GSK announced that the company's vaccine for protection against mumps, measles, and rubella (MMR) had been approved by the U.S...


Developmental and Epileptic Encephalopathy
Evaluation of the Advancing Developmental and Epileptic Encephalopathy Treatment Pipeline

Developmental and Epileptic Encephalopathy (DEE) refers to a group of severe epilepsies that are characterized both by seizures, which are often drug-resistant, as well as encephalopathy, which is...


Pharma News and Analysis for BMS, Sandoz, and Pfizer
BMS Sells NY Biologics Plant; FDA Approves Mitsubishi Tanabe’s Radicava, Love Pharma Acquires Mic...

Love Pharma Completes the Acquisition of MicroDoz Therapy LOVE Pharma Co. has announced the completion of its acquisition of MicroDoz Theraphy Inc. ("MicroDoz"). Love Pharma holds exclusive man...


Gene Therapies Whitepaper
Gene Therapies

Gene therapies are regarded as one of the potential revolution in the Pharmaceutical field and Healt.....

Toll-like Receptors Agonist
Toll-like Receptors Agoni...

Toll-like Receptors (TLRs) are a type of pattern recognition receptor (PRR) that recognizes pathogen.....

Acute Myeloid Leukemia Newsletter
Acute Myeloid Leukemia...

Acute myeloid leukemia (AML), also called acute myelogenous leukemia and acute nonlymphocytic leukem.....

Editor's Pick
Can denovoSkin Be A Lifesaver for Burn Victims?

Burn is a global public health problem, causing more than 180,000 deaths per year acros...

NexoBrid and its Awaiting US Approval

A Burn takes place when the skin comes into contact with a heat source. Burns can occur...

New Clinical Developments in the Pulmonary Arterial Hypertension Treatment Do...

Pulmonary arterial hypertension is a progressive disease of the lung vascular system, p...

Commercial Roadmap for the Launch: What can Biopharmaceuticals do to Increase...

The Pharma and Biotech Healthcare market has been an ever-changing industry in terms of...

Emerging Market for Organ on a Chip

The organ on a chip is a microfluidic culture device that recapitulates the complicated...